Wordt geladen...
Current statuses of molecular targeted and immune checkpoint therapies in hepatocellular carcinoma
Treatment of advanced hepatocellular carcinoma (HCC) still confronts great challenges due to high rate of therapeutic resistance. The emergence of systemic treatment with molecular targeted and immune checkpoint therapies has brought novel approaches towards patients with advanced HCC. However, sora...
Bewaard in:
| Gepubliceerd in: | Am J Cancer Res |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
e-Century Publishing Corporation
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7269783/ https://ncbi.nlm.nih.gov/pubmed/32509395 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|